1 |
Seok D, Smyk N, Jaskir M, Cook P, Elliott M, Girelli T, Scott JC, Balderston N, Beer J, Stock J, Makhoul W, Gur RC, Davatzikos C, Shinohara R, Sheline Y. Dimensional connectomics of anxious misery, a human connectome study related to human disease: Overview of protocol and data quality. Neuroimage Clin 2020;28:102489. [PMID: 33395980 DOI: 10.1016/j.nicl.2020.102489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Alario AA, Niciu MJ. Biomarkers of ketamine's antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology. Chronic Stress (Thousand Oaks) 2021;5:24705470211014210. [PMID: 34159281 DOI: 10.1177/24705470211014210] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
3 |
Siegel JS, Palanca BJA, Ances BM, Kharasch ED, Schweiger JA, Yingling MD, Snyder AZ, Nicol GE, Lenze EJ, Farber NB. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression. Psychopharmacology (Berl) 2021;238:1157-69. [PMID: 33483802 DOI: 10.1007/s00213-021-05762-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Kotoula V, Webster T, Stone J, Mehta MA. Resting-state connectivity studies as a marker of the acute and delayed effects of subanaesthetic ketamine administration in healthy and depressed individuals: A systematic review. Brain Neurosci Adv 2021;5:23982128211055426. [PMID: 34805548 DOI: 10.1177/23982128211055426] [Reference Citation Analysis]
|